Composition
- Active ingredients
- PROCHLORPERAZINE EDISYLATE EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PROCHLORPERAZINE EDISYLATE EQ 10MG BASE/ML · ConcentrateNDA011276-001 · Discontinued
- PROCHLORPERAZINE EDISYLATE EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- PROCHLORPERAZINE EDISYLATE EQ 5MG BASE/5ML · SyrupNDA011188-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA010742.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Compazine
- Active substance
- prochlorperazine edisylate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Glaxosmithkline
- Status
- Discontinued
- FDA approval
- 8 Apr 1957
- Application
- NDA010742-002